Clinical Trials Directory

Trials / Completed

CompletedNCT04568655

The Noninvasive Ventilation to COVID-19 Patients

The Noninvasive Ventilation to COVID-19 Patients With Respiratory Failure

Status
Completed
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.

Detailed description

Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.We wish to raise the success rate to COVID-19 patients with respiratory failure.More critically ill COVID-19 patients could avoid the intubtion.

Conditions

Interventions

TypeNameDescription
DEVICEnoninvasive ventilationnoninvasive ventilation to support the COVID-19 patients with respiratory failure

Timeline

Start date
2020-02-01
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2020-09-29
Last updated
2020-09-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04568655. Inclusion in this directory is not an endorsement.